Prelude Therapeutics Incorporated announced a multi-year, multi-program partnership with Canada-based ABCellra to discover, develop, and commercialize potentially treatments for patients with cancer. “By leveraging our combined capabilities and expertise in rapidly discovering and advancing […]
The post Delaware’s Prelude forms cancer drug development partnership with Canadian company appeared first on Delaware Business Now.
[gs-fb-comments]